Recent progress of national banking project on homozygous HLA ‐typed induced pluripotent stem cells in South Korea
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cells (iPSCs) can be generated by introducing several factors into mature somatic cells. Banking of iPSCs can lead to wider application for treatment and research. In an economical view, it is important to store cells that can cover a high percentage of the population. Therefore, the use of homozygous human leukocyte antigen-iPSCs (HLA-iPSCs) is thought as a potential candidate for effective iPSC banking system for further clinical use. We screened the database stored in the Catholic Hematopoietic Stem Cell Bank of Korea and sorted the most frequent homozygous HLA types of the South Korean population. Blood cells with the selected homozygous HLA types were obtained and transferred to the GMP facility in the Catholic Institute of Cell Therapy. Cells were reprogrammed to iPSCs inside the facility and went through several quality controls. As a result, a total of 13 homozygous GMP-grade iPSC lines were obtained in the facility. The generated iPSCs showed high pluripotency and normal karyotype after reprogramming. Five HLA-homozygous iPSCs had the type that was included in the top five most frequent HLA types. Homozygous HLA-iPSCs can open a new opportunity for further application of iPSCs in clinical research and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A., & Bolton, E. M. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.014 · Cited by 428 · cited 1×
“These three subsets of genes are most important in the HLA loci and reduce the possibility of rejection (Taylor et al., 2012).”
BackgroundPappas, D. J., Gourraud, P.-A., Le Gall, C., Laurent, J., Trounson, A., DeWitt, N., & Talib, S. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0052 · Cited by 57
Cited by
Olgasi, C., Cucci, A., & Follenzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176215 · Cited by 100
Álvarez-Palomo, B., García-Martinez, I., Gayoso, J., Raya, A., Veiga, A., Abad, M. L., Eiras, A., Guzmán-Fulgencio, M., Luis-Hidalgo, M., Eguizabal, C., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02301-0 · Cited by 37
In Vitro Modeling of Atherosclerosis Using iPSC‐Derived Blood Vessel Organoids
Kong, D., Ryu, J., Shin, N., Lee, S., Kim, N. G., Kim, H., Kim, M., Choi, J., Kim, D., & Kang, K. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202400919 · Cited by 36
Kong, D., Kwon, D., Moon, B., Kim, D.-H., Kim, M.-J., Choi, J., & Kang, K.-S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116436 · Cited by 35
Metadata
- Authors
- Rim, Y. A., Park, N., Nam, Y., Ham, D., Kim, J., Ha, H., Jung, J., Jung, S. M., Baek, I. C., Kim, S., Kim, T., Song, J., Lee, J., Park, S., Chung, N., Yoon, K., & Ju, J. H.
- Venue
- Journal of Tissue Engineering and Regenerative Medicine
- Publisher
- Wiley
- Published
- 2017-11-10
- Volume
- 12
- Issue
- 3
- Pages
- e1531-e1536
- ISSN
- 1932-6254 (ISSN-L)
- 1932-7005
- OpenAlex
- W2757292008
- Cited by
- 70
- References
- 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent progress of national banking project on homozygous HLA ‐typed induced pluripotent stem cells in South Korea. https://app.cochat.ai/papers/10.1002/term.2578
- The paper
- Rim, Y. A., Park, N., Nam, Y., Ham, D., Kim, J., Ha, H., Jung, J., Jung, S. M., Baek, I. C., Kim, S., Kim, T., Song, J., Lee, J., Park, S., Chung, N., Yoon, K., & Ju, J. H. (2018). Recent progress of national banking project on homozygous HLA ‐typed induced pluripotent stem cells in South Korea. Journal of Tissue Engineering and Regenerative Medicine. https://doi.org/10.1002/term.2578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.